Specialized Solutions for CROs and the Biotechnology Industry

Base Científica is a national leader in supporting CROs and pharmaceutical companies seeking excellence in clinical research, method validation, and access to the Brazilian market.

We combine local expertise in ANVISA regulation with international quality and compliance standards, including ISO OECD-Good Laboratory Practice (GLP) and ICH.

Our work accelerates regulatory approvals, optimizes operational costs, and ensures scientific reliability and full traceability of results.

Our Services

Our Differentiators

Why choose Scientific Base?

Customized and scalable scientific validation for R&D.

Molecular Biology and Advanced Cellular Research for Biotechnology Companies

Your Independent and Personalized Biotechnology Laboratory

PRODUCT VALIDATIONS

We develop and validate biological assays for drug evaluations, diagnostics, and therapeutic applications. This includes ensuring that the assays are reproducible and can be used reliably in clinical settings.

BIOBANK

We collect, process and store biological samples for research purposes: Cell Lines and Genetic Material.

MOLECULAR DIAGNOSTICS

We develop and optimize molecular assays for the detection of pathogens, genetic mutations, and biomarkers. This includes the use of techniques such as PCR (Polymerase Chain Reaction) and NGS sequencing.

PRECLINICAL EFFICACY & SAFETY TRIALS

We perform cell line authentication and functional characterization to ensure cell viability and cytotoxicity. We standardize methods and ensure genomic stability to facilitate the discovery of new antitumor compounds, using 2D and 3D culture models.

3D CULTIVATION OF ORGANOIDS

We use the patient's own tumor cells, along with models that simulate the physiology and complexity of the disease, to enable personalized treatment selection and the exploration of new compounds. Optimized and validated culture methods are essential to ensure the efficacy of these approaches.

Development of personalized artificial intelligence agents

We offer agile AI agent prototyping and development solutions to optimize R&D processes, including automating laboratory workflows to increase efficiency and effectiveness, as well as advanced analysis of biological and multi-omics data, providing insights to accelerate decision-making.

Clients & Testimonials

HOSPITALS

LABORATORIES

PHARMACEUTICALS

BIOTECHNOLOGY

CRO

DISTRIBUTORS

Infectious Diseases, Oncology, Genetics, Immunology and Microbiome

Our purpose is to drive advances in product validation and clinical trials in molecular biology and cellular research in Latin America, focusing on improving therapeutic outcomes and strengthening the connection between human health and molecular biology. Together, we seek to facilitate innovative discoveries that meet industry needs and transform lives, contributing to improving quality of life worldwide.

Alexandra Reis, PhD, USP

Founder, CEO & CSO

Keeping an Eye on Our Growth

+100

CUSTOMERS

600k

PROCESSED SAMPLES

+150

VALIDATIONS & RESEARCH

+30

CLINICAL TRIALS